HEADER TRANSFERASE 27-MAY-04 1VZU TITLE ROLES OF ACTIVE SITE TRYPTOPHANS IN SUBSTRATE BINDING AND CATALYSIS BY TITLE 2 ALPHA-1,3 GALACTOSYLTRANSFERASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 80-368; COMPND 5 SYNONYM: GALACTOSYLTRANSFERASE, UDP-GALACTOSE, BETA-D-GALACTOSYL-1,4- COMPND 6 N-ACETYL-D-GLUCOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE; COMPND 7 EC: 2.4.1.151; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: RESIDUE W314Y SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI DH5[ALPHA]; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 668369; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PSV-SPORT KEYWDS TRANSFERASE, GLYCOSYLTRANSFERASE, GLYCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.ZHANG,A.DESHPANDE,Z.XIE,R.NATESH,K.R.ACHARYA,K.BREW REVDAT 6 29-JUL-20 1VZU 1 COMPND REMARK HET HETNAM REVDAT 6 2 1 HETSYN FORMUL LINK SITE REVDAT 6 3 1 ATOM REVDAT 5 28-FEB-18 1VZU 1 SOURCE JRNL REVDAT 4 06-OCT-09 1VZU 1 KEYWDS REMARK HETNAM SITE REVDAT 3 24-FEB-09 1VZU 1 VERSN REVDAT 2 03-NOV-04 1VZU 1 JRNL REVDAT 1 08-JUL-04 1VZU 0 JRNL AUTH Y.ZHANG,A.DESHPANDE,Z.XIE,R.NATESH,K.R.ACHARYA,K.BREW JRNL TITL ROLES OF ACTIVE SITE TRYPTOPHANS IN SUBSTRATE BINDING AND JRNL TITL 2 CATALYSIS BY ALPHA-1,3 GALACTOSYLTRANSFERASE. JRNL REF GLYCOBIOLOGY V. 14 1295 2004 JRNL REFN ISSN 0959-6658 JRNL PMID 15229192 JRNL DOI 10.1093/GLYCOB/CWH119 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.ZHANG,G.J.SWAMINATHAN,A.DESHPANDE,E.BOIX,R.NATESH,Z.XIE, REMARK 1 AUTH 2 K.R.ACHARYA,K.BREW REMARK 1 TITL ROLES OF INDIVIDUAL ENZYME-SUBSTRATE INTERACTIONS BY REMARK 1 TITL 2 ALPHA-1,3-GALACTOSYLTRANSFERASE IN CATALYSIS AND SPECIFICITY REMARK 1 REF BIOCHEMISTRY V. 42 13512 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 14621997 REMARK 1 DOI 10.1021/BI035430R REMARK 1 REFERENCE 2 REMARK 1 AUTH L.N.GASTINAL,C.BIGNON,A.K.MISRA,O.HINDSGAUL,J.H.SHAPER, REMARK 1 AUTH 2 D.H.JOZIASSE REMARK 1 TITL BOVINE ALPHA1,3-GALACTOSYLTRANSFERASE CATALYTIC DOMAIN REMARK 1 TITL 2 STRUCTURE AND ITS RELATIONSHIP WITH ABO HHISTO-BLOOD GROUP REMARK 1 TITL 3 AND GLYCOPHINGOLIPID GLYCOSYLTRANSFERASES REMARK 1 REF EMBO J. V. 20 638 2001 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 11179209 REMARK 1 DOI 10.1093/EMBOJ/20.4.638 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.BOIX,G.J.SWAMINATHAN,Y.ZHANG,R.NATESH,K.BREW,K.R.ACHARYA REMARK 1 TITL STRUCTURE OF UDP COMPLEX OF REMARK 1 TITL 2 UDP-GALACTOSE:BETA-GALACTOSIDE-ALPHA-1, REMARK 1 TITL 3 3-GALACTOSYLTRANSFERASE AT 1.53-A RESOLUTION REVEALS A REMARK 1 TITL 4 CONFORMATIONAL CHANGE IN THE CATALYTICALLY IMPORTANT C REMARK 1 TITL 5 TERMINUS REMARK 1 REF J.BIOL.CHEM. V. 276 48608 2001 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 11592969 REMARK 1 DOI 10.1074/JBC.M108828200 REMARK 2 REMARK 2 RESOLUTION. 1.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 476623 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.154 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 8218 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4782 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 110 REMARK 3 SOLVENT ATOMS : 863 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1VZU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-MAY-04. REMARK 100 THE DEPOSITION ID IS D_1290015355. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 84060 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1K4V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6000, TRIS/HCL, PH 8.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.84200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 TRANSFER OF GALACTOSE FROM UDP-GALACTOSE TO AN ACCEPTOR REMARK 400 MOLECULE. REMARK 400 UDP-GALACTOSE + BETA-D-GALACTOSYL-(1,4)-N-ACETYL-D- REMARK 400 GLUCOSAMINYL-R = UDP + ALPHA-D-GALACTOSYL-(1,3)-B REMARK 400 GALACTOSYL-(1,4)-N-ACETYL-D-GLUCOSAMINYL-R. REMARK 400 REMARK 400 ENGINEERED MUTATION TRP 314 TYR, CHAINS A AND B REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 80 REMARK 465 SER A 81 REMARK 465 GLU B 1080 REMARK 465 SER B 1081 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 138 CD - NE - CZ ANGL. DEV. = 11.7 DEGREES REMARK 500 TYR A 251 CB - CG - CD1 ANGL. DEV. = -3.7 DEGREES REMARK 500 TYR A 323 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ASP B1169 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG B1194 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG B1194 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG B1263 NE - CZ - NH1 ANGL. DEV. = -3.8 DEGREES REMARK 500 TYR B1323 CB - CG - CD2 ANGL. DEV. = -4.0 DEGREES REMARK 500 TYR B1323 CB - CG - CD1 ANGL. DEV. = 4.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 104 20.22 80.09 REMARK 500 LEU A 175 62.60 -105.97 REMARK 500 HIS A 213 -35.37 -154.67 REMARK 500 HIS A 315 -132.30 51.62 REMARK 500 CYS A 338 79.66 -162.32 REMARK 500 HIS B1213 -33.95 -152.04 REMARK 500 THR B1259 45.92 -86.50 REMARK 500 HIS B1315 -129.43 46.80 REMARK 500 CYS B1338 81.71 -162.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2030 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH A2054 DISTANCE = 6.28 ANGSTROMS REMARK 525 HOH A2086 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH B4124 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH B4170 DISTANCE = 6.45 ANGSTROMS REMARK 525 HOH B4301 DISTANCE = 6.26 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A1369 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 225 OD2 REMARK 620 2 ASP A 227 OD1 98.7 REMARK 620 3 ASP A 227 OD2 156.0 57.5 REMARK 620 4 UDP A1371 O1A 97.1 82.4 78.1 REMARK 620 5 UDP A1371 O1B 102.6 158.5 101.1 91.7 REMARK 620 6 HOH A2408 O 95.5 97.8 91.2 167.2 83.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN B2369 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B1225 OD2 REMARK 620 2 ASP B1227 OD2 156.3 REMARK 620 3 ASP B1227 OD1 99.6 56.7 REMARK 620 4 UDP B2371 O1A 100.0 78.4 82.4 REMARK 620 5 UDP B2371 O1B 100.0 103.7 160.3 92.5 REMARK 620 6 HOH B4434 O 93.6 91.4 101.0 165.3 79.5 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FG5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BOVINE ALPHA-1,3- REMARK 900 GALACTOSYLTRANSFERASECATALYTIC DOMAIN. REMARK 900 RELATED ID: 1G8O RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC STRUCTURE OF THE NATIVE BOVINE ALPHA-1,3- REMARK 900 GALACTOSYLTRANSFERASE CATALYTIC DOMAIN REMARK 900 RELATED ID: 1G93 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE BOVINE CATALYTIC DOMAIN OF ALPHA-1,3- REMARK 900 GALACTOSYLTRANSFERASE IN THE PRESENCE OF UDP-GALACTOSE REMARK 900 RELATED ID: 1GWV RELATED DB: PDB REMARK 900 STRUCTURAL BASIS OF ORDERED BINDING OF DONOR AND ACCEPTOR REMARK 900 SUBSTRATES TO THE RETAINING GLYCOSYLTRANSFERASE: ALPHA -1,3 REMARK 900 GALACTOSYLTRANSFERASE REMARK 900 RELATED ID: 1GWW RELATED DB: PDB REMARK 900 STRUCTURAL BASIS OF ORDERED BINDING OF DONOR AND ACCEPTOR REMARK 900 SUBSTRATES TO THE RETAINING GLYCOSYLTRANSFERASE: ALPHA -1,3 REMARK 900 GALACTOSYLTRANSFERASE REMARK 900 RELATED ID: 1GX0 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS OF ORDERED BINDING OF DONOR AND ACCEPTOR REMARK 900 SUBSTRATES TO THE RETAINING GLYCOSYLTRANSFERASE: ALPHA -1,3 REMARK 900 GALACTOSYLTRANSFERASE REMARK 900 RELATED ID: 1GX4 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS OF ORDERED BINDING OF DONOR AND ACCEPTOR REMARK 900 SUBSTRATES TO THE RETAINING GLYCOSYLTRANSFERASE: ALPHA -1,3 REMARK 900 GALACTOSYLTRANSFERASE REMARK 900 RELATED ID: 1K4V RELATED DB: PDB REMARK 900 1.53 A CRYSTAL STRUCTURE OF THE BETA- GALACTOSIDE-ALPHA-1,3- REMARK 900 GALACTOSYLTRANSFERASE IN COMPLEX WITH UDP REMARK 900 RELATED ID: 1O7O RELATED DB: PDB REMARK 900 ROLES OF INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN REMARK 900 SUBSTRATE BINDING AND CATALYSIS REMARK 900 RELATED ID: 1O7Q RELATED DB: PDB REMARK 900 ROLES OF INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN REMARK 900 SUBSTRATE BINDING AND CATALYSIS REMARK 900 RELATED ID: 1O7R RELATED DB: PDB REMARK 900 ROLES ON INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN REMARK 900 SUBSTRATE BINDING AND CATALYSIS REMARK 900 RELATED ID: 1VZT RELATED DB: PDB REMARK 900 ROLES ON INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN REMARK 900 SUBSTRATE BINDING AND CATALYSIS REMARK 900 RELATED ID: 1VZX RELATED DB: PDB REMARK 900 ROLES OF ACTIVE SITE TRYPTOPHANS IN SUBSTRATE BINDING AND CATALYSIS REMARK 900 BY ALPHA-1, 3 GALACTOSYLTRANSFERASE DBREF 1VZU A 80 368 UNP P14769 GATR_BOVIN 80 368 DBREF 1VZU B 1080 1368 UNP P14769 GATR_BOVIN 80 368 SEQADV 1VZU TYR A 314 UNP P14769 TRP 314 ENGINEERED MUTATION SEQADV 1VZU TYR B 1314 UNP P14769 TRP 314 ENGINEERED MUTATION SEQRES 1 A 289 GLU SER LYS LEU LYS LEU SER ASP TRP PHE ASN PRO PHE SEQRES 2 A 289 LYS ARG PRO GLU VAL VAL THR MET THR LYS TRP LYS ALA SEQRES 3 A 289 PRO VAL VAL TRP GLU GLY THR TYR ASN ARG ALA VAL LEU SEQRES 4 A 289 ASP ASN TYR TYR ALA LYS GLN LYS ILE THR VAL GLY LEU SEQRES 5 A 289 THR VAL PHE ALA VAL GLY ARG TYR ILE GLU HIS TYR LEU SEQRES 6 A 289 GLU GLU PHE LEU THR SER ALA ASN LYS HIS PHE MET VAL SEQRES 7 A 289 GLY HIS PRO VAL ILE PHE TYR ILE MET VAL ASP ASP VAL SEQRES 8 A 289 SER ARG MET PRO LEU ILE GLU LEU GLY PRO LEU ARG SER SEQRES 9 A 289 PHE LYS VAL PHE LYS ILE LYS PRO GLU LYS ARG TRP GLN SEQRES 10 A 289 ASP ILE SER MET MET ARG MET LYS THR ILE GLY GLU HIS SEQRES 11 A 289 ILE VAL ALA HIS ILE GLN HIS GLU VAL ASP PHE LEU PHE SEQRES 12 A 289 CYS MET ASP VAL ASP GLN VAL PHE GLN ASP LYS PHE GLY SEQRES 13 A 289 VAL GLU THR LEU GLY GLU SER VAL ALA GLN LEU GLN ALA SEQRES 14 A 289 TRP TRP TYR LYS ALA ASP PRO ASN ASP PHE THR TYR GLU SEQRES 15 A 289 ARG ARG LYS GLU SER ALA ALA TYR ILE PRO PHE GLY GLU SEQRES 16 A 289 GLY ASP PHE TYR TYR HIS ALA ALA ILE PHE GLY GLY THR SEQRES 17 A 289 PRO THR GLN VAL LEU ASN ILE THR GLN GLU CYS PHE LYS SEQRES 18 A 289 GLY ILE LEU LYS ASP LYS LYS ASN ASP ILE GLU ALA GLN SEQRES 19 A 289 TYR HIS ASP GLU SER HIS LEU ASN LYS TYR PHE LEU LEU SEQRES 20 A 289 ASN LYS PRO THR LYS ILE LEU SER PRO GLU TYR CYS TRP SEQRES 21 A 289 ASP TYR HIS ILE GLY LEU PRO ALA ASP ILE LYS LEU VAL SEQRES 22 A 289 LYS MET SER TRP GLN THR LYS GLU TYR ASN VAL VAL ARG SEQRES 23 A 289 ASN ASN VAL SEQRES 1 B 289 GLU SER LYS LEU LYS LEU SER ASP TRP PHE ASN PRO PHE SEQRES 2 B 289 LYS ARG PRO GLU VAL VAL THR MET THR LYS TRP LYS ALA SEQRES 3 B 289 PRO VAL VAL TRP GLU GLY THR TYR ASN ARG ALA VAL LEU SEQRES 4 B 289 ASP ASN TYR TYR ALA LYS GLN LYS ILE THR VAL GLY LEU SEQRES 5 B 289 THR VAL PHE ALA VAL GLY ARG TYR ILE GLU HIS TYR LEU SEQRES 6 B 289 GLU GLU PHE LEU THR SER ALA ASN LYS HIS PHE MET VAL SEQRES 7 B 289 GLY HIS PRO VAL ILE PHE TYR ILE MET VAL ASP ASP VAL SEQRES 8 B 289 SER ARG MET PRO LEU ILE GLU LEU GLY PRO LEU ARG SER SEQRES 9 B 289 PHE LYS VAL PHE LYS ILE LYS PRO GLU LYS ARG TRP GLN SEQRES 10 B 289 ASP ILE SER MET MET ARG MET LYS THR ILE GLY GLU HIS SEQRES 11 B 289 ILE VAL ALA HIS ILE GLN HIS GLU VAL ASP PHE LEU PHE SEQRES 12 B 289 CYS MET ASP VAL ASP GLN VAL PHE GLN ASP LYS PHE GLY SEQRES 13 B 289 VAL GLU THR LEU GLY GLU SER VAL ALA GLN LEU GLN ALA SEQRES 14 B 289 TRP TRP TYR LYS ALA ASP PRO ASN ASP PHE THR TYR GLU SEQRES 15 B 289 ARG ARG LYS GLU SER ALA ALA TYR ILE PRO PHE GLY GLU SEQRES 16 B 289 GLY ASP PHE TYR TYR HIS ALA ALA ILE PHE GLY GLY THR SEQRES 17 B 289 PRO THR GLN VAL LEU ASN ILE THR GLN GLU CYS PHE LYS SEQRES 18 B 289 GLY ILE LEU LYS ASP LYS LYS ASN ASP ILE GLU ALA GLN SEQRES 19 B 289 TYR HIS ASP GLU SER HIS LEU ASN LYS TYR PHE LEU LEU SEQRES 20 B 289 ASN LYS PRO THR LYS ILE LEU SER PRO GLU TYR CYS TRP SEQRES 21 B 289 ASP TYR HIS ILE GLY LEU PRO ALA ASP ILE LYS LEU VAL SEQRES 22 B 289 LYS MET SER TRP GLN THR LYS GLU TYR ASN VAL VAL ARG SEQRES 23 B 289 ASN ASN VAL HET BGC C 1 12 HET GAL C 2 11 HET BGC D 1 12 HET GAL D 2 11 HET MN A1369 1 HET UDP A1371 25 HET GOL A1372 6 HET MN B2369 1 HET UDP B2371 25 HET GOL B2372 6 HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM MN MANGANESE (II) ION HETNAM UDP URIDINE-5'-DIPHOSPHATE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 BGC 2(C6 H12 O6) FORMUL 3 GAL 2(C6 H12 O6) FORMUL 5 MN 2(MN 2+) FORMUL 6 UDP 2(C9 H14 N2 O12 P2) FORMUL 7 GOL 2(C3 H8 O3) FORMUL 11 HOH *863(H2 O) HELIX 1 1 LYS A 84 PHE A 89 1 6 HELIX 2 2 ASN A 90 ARG A 94 5 5 HELIX 3 3 ASN A 114 LYS A 126 1 13 HELIX 4 4 ARG A 138 PHE A 155 1 18 HELIX 5 5 ASP A 169 MET A 173 5 5 HELIX 6 6 ARG A 194 HIS A 213 1 20 HELIX 7 7 HIS A 213 VAL A 218 1 6 HELIX 8 8 GLY A 235 LEU A 239 5 5 HELIX 9 9 ASP A 254 PHE A 258 5 5 HELIX 10 10 THR A 287 ASN A 308 1 22 HELIX 11 11 TYR A 314 ASN A 327 1 14 HELIX 12 12 PRO A 335 CYS A 338 5 4 HELIX 13 13 ASP A 340 GLY A 344 5 5 HELIX 14 14 GLU A 360 ARG A 365 1 6 HELIX 15 15 LYS B 1084 PHE B 1089 1 6 HELIX 16 16 ASN B 1090 ARG B 1094 5 5 HELIX 17 17 ASN B 1114 LYS B 1126 1 13 HELIX 18 18 ARG B 1138 PHE B 1155 1 18 HELIX 19 19 ASP B 1169 MET B 1173 5 5 HELIX 20 20 ARG B 1194 VAL B 1218 1 25 HELIX 21 21 GLY B 1235 LEU B 1239 5 5 HELIX 22 22 ASP B 1254 PHE B 1258 5 5 HELIX 23 23 THR B 1287 ASN B 1308 1 22 HELIX 24 24 TYR B 1314 ASN B 1327 1 14 HELIX 25 25 PRO B 1335 CYS B 1338 5 4 HELIX 26 26 ASP B 1340 GLY B 1344 5 5 HELIX 27 27 GLU B 1360 ARG B 1365 1 6 SHEET 1 AA 8 VAL A 107 VAL A 108 0 SHEET 2 AA 8 LYS A 331 LEU A 333 1 O ILE A 332 N VAL A 108 SHEET 3 AA 8 SER A 242 LEU A 246 1 O SER A 242 N LYS A 331 SHEET 4 AA 8 TYR A 279 GLY A 286 -1 N HIS A 280 O GLN A 245 SHEET 5 AA 8 PHE A 220 MET A 224 -1 O LEU A 221 N GLY A 286 SHEET 6 AA 8 VAL A 129 ALA A 135 1 O GLY A 130 N PHE A 222 SHEET 7 AA 8 VAL A 161 VAL A 167 1 O ILE A 162 N LEU A 131 SHEET 8 AA 8 ARG A 182 LYS A 188 1 O SER A 183 N PHE A 163 SHEET 1 AB 2 GLN A 228 PHE A 230 0 SHEET 2 AB 2 MET A 354 TRP A 356 -1 O SER A 355 N VAL A 229 SHEET 1 BA 8 VAL B1107 VAL B1108 0 SHEET 2 BA 8 LYS B1331 LEU B1333 1 O ILE B1332 N VAL B1108 SHEET 3 BA 8 SER B1242 LEU B1246 1 O SER B1242 N LYS B1331 SHEET 4 BA 8 TYR B1279 GLY B1286 -1 N HIS B1280 O GLN B1245 SHEET 5 BA 8 PHE B1220 MET B1224 -1 O LEU B1221 N GLY B1286 SHEET 6 BA 8 VAL B1129 ALA B1135 1 O GLY B1130 N PHE B1222 SHEET 7 BA 8 VAL B1161 VAL B1167 1 O ILE B1162 N LEU B1131 SHEET 8 BA 8 ARG B1182 LYS B1188 1 O SER B1183 N PHE B1163 SHEET 1 BB 2 GLN B1228 PHE B1230 0 SHEET 2 BB 2 MET B1354 TRP B1356 -1 O SER B1355 N VAL B1229 LINK O4 BGC C 1 C1 GAL C 2 1555 1555 1.41 LINK O4 BGC D 1 C1 GAL D 2 1555 1555 1.41 LINK OD2 ASP A 225 MN MN A1369 1555 1555 2.14 LINK OD1 ASP A 227 MN MN A1369 1555 1555 2.15 LINK OD2 ASP A 227 MN MN A1369 1555 1555 2.40 LINK MN MN A1369 O1A UDP A1371 1555 1555 2.25 LINK MN MN A1369 O1B UDP A1371 1555 1555 2.13 LINK MN MN A1369 O HOH A2408 1555 1555 2.17 LINK OD2 ASP B1225 MN MN B2369 1555 1555 2.15 LINK OD2 ASP B1227 MN MN B2369 1555 1555 2.40 LINK OD1 ASP B1227 MN MN B2369 1555 1555 2.17 LINK MN MN B2369 O1A UDP B2371 1555 1555 2.17 LINK MN MN B2369 O1B UDP B2371 1555 1555 2.10 LINK MN MN B2369 O HOH B4434 1555 1555 2.17 CRYST1 44.858 93.684 93.714 90.00 99.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022293 0.000000 0.003531 0.00000 SCALE2 0.000000 0.010674 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010804 0.00000 MASTER 403 0 10 27 20 0 0 6 0 0 0 46 END